Medical Weight Loss in Tampa Bay
Real exam. Real labs. A provider who monitors your progress — not a questionnaire. Medication filled at your pharmacy, billed directly to you at cost. We don't mark up your prescription.
Real Provider. Real Exam. Real Results.
In-person medical weight loss support with labs, education, prescription management, and ongoing monitoring.
$149
One-time
- Initial consultation and comprehensive physical exam
- Full metabolic lab panel ordered and interpreted by your provider; lab processing is completed by an independent third-party lab and billed separately
- BMI and eligibility documentation
- Written informed consent
- Prescription sent to your pharmacy of choice
- In-person injection training
$99/mo
No commitment
- One free telehealth visit every 3 months — live video check-in with your provider, refill authorization, side-effect review
- In-person visit every 90 days for weigh-in, documentation, and physical exam
- Progress tracking between visits
- Direct line to your care team
$79/mo
12-month subscription
- One free telehealth visit every 3 months — live video check-in with your provider, refill authorization, side-effect review
- In-person visit every 90 days for weigh-in, documentation, and physical exam
- Progress tracking between visits
- Direct line to your care team
$499/mo
- Everything in Monitoring
- Weekly B12 injections
- Monthly IV hydration session
- Priority scheduling
Program fees cover your medical care — consultation, labs ordered and interpreted by your provider, monitoring, and training. Lab processing is performed by an independent third-party lab such as Labcorp or Quest and billed to you separately by that lab. Medication is filled at your pharmacy or through the manufacturer's direct program and billed to you separately, at no markup.
Why not just use Ro or Hims?
Ro, Hims, Found
- Generic online questionnaire
- No physical exam
- Mail pharmacy workflow or limited pharmacy options
- No injection training
- No monitoring
In-person medical weight loss
- ✓Real provider, real exam
- ✓Full metabolic labs before prescribing
- ✓Medication available after labs are reviewed and medication is deemed clinically appropriate
- ✓No markup on medication — you pay your pharmacy or manufacturer program directly
- ✓Monthly video visits with your provider — not just a form
- ✓In-person injection training
- ✓Monthly accountability check-ins
- ✓Bilingual Spanish/English
Four steps to start
Book a consultation — same day available
Complete labs + provider evaluation
Prescription sent to your pharmacy or manufacturer direct program
Monthly live check-ins, monitoring, and refill authorization when appropriate
Real Provider. Real Exam. Real Results.
✓In-person exam before prescribing
✓Labs reviewed by your provider
✓Injection technique taught in office
✓Bilingual English/Spanish providers
✓Medication available after labs are reviewed and medication is deemed clinically appropriate — no medication markup
What is semaglutide?
Semaglutide is a GLP-1 medication that can support appetite control, blood sugar regulation, and weight loss when prescribed as part of a supervised medical plan.
Am I a candidate for medical weight loss?
Candidacy depends on your medical history, medications, weight goals, lab results, and provider evaluation. Castellan Health reviews these factors before prescribing.
How much weight can I expect to lose?
Results vary. Weight loss depends on medication response, nutrition, activity, adherence, and underlying health conditions.
Do you accept insurance for weight loss?
No. Medical weight loss is offered as a transparent cash-pay service with no insurance required.
What's the difference between semaglutide and tirzepatide?
Semaglutide targets GLP-1 receptors, while tirzepatide targets GLP-1 and GIP pathways. Your provider can help determine which option is clinically appropriate.
Why We Don't Just Write the Prescription
Some competitors will ship you a GLP-1 medication after a five-minute online form — no exam, no labs, no real relationship with a provider. We won't. That's not a difference in style. It's the difference between medicine and a transaction.
A GLP-1 prescription is not a low-risk decision. These medications carry real, documented risks — GI intolerance severe enough to cause dehydration, gallbladder disease, pancreatitis, and a boxed warning around thyroid C-cell tumors that rules certain patients out entirely based on personal or family history. The FDA issued warning letters to dozens of GLP-1 sellers in 2025 and again in 2026 over misleading marketing and dosing practices tied to real hospitalizations. A questionnaire cannot screen for any of the risks above. A physical exam and baseline labs can. That is the difference between a provider making a clinical decision and a website processing an order.
Documentation is not paperwork for its own sake. It is the record that proves every dose increase, every side effect, and every decision to continue treatment was made on clinical grounds — not because a subscription auto-renewed. If a patient has a bad outcome and the chart shows no exam, no labs, and no documented clinical reasoning, that is not treatment. That is exposure — for the patient, and for whoever prescribed it.
Ongoing monitoring is not a courtesy. It exists to catch problems while they're still manageable: nausea that needs a slower titration, a side effect that needs active management before a patient quietly quits on their own, a dose that needs adjusting based on how someone is actually responding. That is a conversation with a provider — not a refill button.
And treatment does not continue indefinitely by default. If a patient shows no meaningful response after about three months on an appropriate dose, our standard is to stop and reassess — adjust the plan, address adherence or lifestyle factors, or discontinue. We do not keep billing a patient for a medication that isn't working. Full stop.
Off-Label Use: What It Means and How We Handle It
Semaglutide and tirzepatide are FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition. Prescribing outside that labeled population is called off-label use. Off-label prescribing is legal, common, and a normal part of medical practice — a licensed provider retains the authority to prescribe an FDA-approved medication based on individual clinical judgment, independent of what an insurer would or wouldn't cover. It is not a loophole. It is how medicine has always worked.
At Castellan Health, this comes up for self-pay patients who don't meet the labeled BMI or comorbidity threshold but may still be reasonable candidates once a provider actually evaluates them. Eligibility in these cases is determined at your consultation, on an individual basis — not assumed in advance, and not extended automatically just because a patient is paying cash.
Off-label does not mean a lower standard of care. It means the same exam, the same labs, the same documentation, the same monitoring, and the same three-month response check described above — applied to a broader population, with clear informed consent that the specific use is off-label. What we won't do is prescribe off-label without a real exam, or simply because a patient asked and can pay. That is the same standard we hold for every patient, on-label or not.